Collegium Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. 

CEO
Vikram Karnani
CEOVikram Karnani
Employees
423
Employees423
Headquarters
Stoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded
2002
Founded2002
Employees
423
Employees423

COLL Key Statistics

Market cap
1.01B
Market cap1.01B
Price-Earnings ratio
18.44
Price-Earnings ratio18.44
Dividend yield
Dividend yield
Average volume
711.63K
Average volume711.63K
High today
High today
Low today
Low today
Open price
$32.62
Open price$32.62
Volume
0.00
Volume0.00
52 Week high
$50.79
52 Week high$50.79
52 Week low
$23.23
52 Week low$23.23

Stock Snapshot

Collegium Pharmaceutical(COLL) stock is priced at $31.99, giving the company a market capitalization of 1.01B. It carries a P/E multiple of 18.44.

During the trading day, Collegium Pharmaceutical(COLL) stock saw an opening price of $32.62, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 711.63K.

Over the past 52 weeks, Collegium Pharmaceutical(COLL) stock has traded between a high of $50.79 and a low of $23.23.

Over the past 52 weeks, Collegium Pharmaceutical(COLL) stock has traded between a high of $50.79 and a low of $23.23.

COLL News

Nasdaq 11h
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD

Key Points 6,224 shares were sold for a transaction value of ~$228,000 on March 9, 2026. This sale represented 6.40% of Dieter David’s direct holdings prior t...

Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.